Osteoporosis – Pipeline Assessment And Market Forecasts To 2017

{flickr|100|campaign} Aarkstore announce a new report “Osteoporosis – Pipeline Assessment and Market Forecasts to 2017 ” through its vast collection of market research report.


The industry analysis specialist, has released its new report, Osteoporosis – Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Osteoporosis therapeutics market. The report identifies the key trends shaping and driving the global Osteoporosis therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Osteoporosis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

The global osteoporosis therapeutics market was valued at $ 9.6 billion in 2009. It is expected to grow to $ 18.2 billion by 2017 at a Compound Annual Growth Rate (CAGR) of 8.2%. This significant growth is primarily attributed to the strong current treatment options as well as strong pipeline candidates. An increase in the prevalence of osteoporosis among the female population is the principal driver of the osteoporosis market and will continue to be in the future. The significant reason for the increase in prevalence is due to the decline in the use of Hormone Replacement Therapy (HRT) in healthy postmenopausal women. HRT has been used to help prevent the bone loss that leads to osteoporosis. However, recent negative study results, showing an increased risk of heart attacks, stroke, breast cancer and blood clots, have led to a decline in HRT usage. Therefore, a decline in the use of HRT and an increase in the diseased population will combine to contribute to the increased burden of osteoporosis.


The scope of the report includes:
– Annualized global Osteoporosis therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
– Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
– Pipeline analysis data provides a split across the different phases, mechanisms of action being developed and emerging trends. The molecules under development for osteoporosis can be categorized as calcium modulators, CTSK inhibitors, bone-tissue resorption inhibitors and SERMs.
– Analysis of the current and future market competition in the global osteoporosis therapeutics market. The key future market players covered are Amgen, Ligand Pharmaceuticals Incorporated, Osteologix, Novartis AG, GlaxoSmithKline Inc,
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
– Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the osteoporosis market.

For more information, please visit:
Or email us at press@aarkstore.com or call +919272852585